glp-1 logo Are GLP-1s Longevity Drugs? GLP-1-based (glucagon-like peptide-1) diabetes drug

At Avena, peptide therapy is offered with the understanding that each patients experience is unique, and treatment must adapt accordingly

It is administered through subcutaneous injection and has been found to be safe and effective in clinical trials

At this dosage, the duration of such trials should last no longer than 8-12 weeks

Some members say the customer service team could use better training, reporting slow or unhelpful responses when trying to resolve issues

"There's a theory the free radical theory of aging that's been around for a long time that says when we oxidize our food to produce energy there's a number of free radicals that are produced that are side products of that action and many of these are quite toxic," said Beelman